2020
Substance Use Disorder Detection Rates Among Providers of General Medical Inpatients
Serowik KL, Yonkers KA, Gilstad-Hayden K, Forray A, Zimbrean P, Martino S. Substance Use Disorder Detection Rates Among Providers of General Medical Inpatients. Journal Of General Internal Medicine 2020, 36: 668-675. PMID: 33111239, PMCID: PMC7947066, DOI: 10.1007/s11606-020-06319-7.Peer-Reviewed Original ResearchConceptsSubstance use disordersUse disordersMedical inpatientsPatient characteristicsMedical recordsGeneral medical inpatient unitsPatient self-report questionnairesGeneral medical inpatientsMedical inpatient unitsOpioid use disorderDrug use disordersNicotine use disorderPatients' medical recordsCannabis use disorderLarge teaching hospitalAlcohol use disorderDetection rateCocaine use disorderWhite patientsBlack patientsFemale patientsHispanic patientsFormal screeningInpatient providersTeaching hospital
2007
Development of a functional assessment of side-effects to therapy (FAST) questionnaire to assess dermatology-related quality of life in patients treated with EGFR inhibitors (EGFRI): The FAST-EGFRI
Wagner L, Lai S, Aneja M, Lorusso P, Perez-Soler R, O’Brien B, Patel J, Lacouture M. Development of a functional assessment of side-effects to therapy (FAST) questionnaire to assess dermatology-related quality of life in patients treated with EGFR inhibitors (EGFRI): The FAST-EGFRI. Journal Of Clinical Oncology 2007, 25: 19532-19532. DOI: 10.1200/jco.2007.25.18_suppl.19532.Peer-Reviewed Original ResearchDisease-specific HRQL questionnairePatient self-report questionnairesHealth-related qualityBeneficial antitumor effectsEGFRI therapyDermatological toxicitiesHRQL questionnairesSkindex-29Self-report questionnairesAntitumor effectsBothersome aspectHRQLPatientsExpert cliniciansLife factorsHair alterationsQuestionnaireEGFRIsPruritusRashParonychiaTherapySymptomsCliniciansExpert input
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply